City

Bruxelles (1)

Campinas (1)

Condition

Moxifloxacin (2)

Endophthalmitis (1)

Lung Disease (1)

Open Globe Injury (1)

Post-Traumatic Endophthalmitis (1)

Pulmonary Disease (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Pfizer (1)

University of Campinas, Brazil (1)

Collaborator

Intervention

ciprofloxacin 400 mg/200 ml intravenous solution [cipro iv] (1)

moxifloxacin (1)

moxifloxacin ophthalmic 0.5% ophthalmic solution (1)

pf-00610355 (1)

placebo (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

moxifloxacin

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Endophthalmitis, Open Globe Injury, Moxifloxacin Trial in Campinas (Moxifloxacin Ophthalmic 0.5% Ophthalmic Solution,

Recruiting

Endophthalmitis
+3 more

Moxifloxacin Ophthalmic 0.5% Ophthalmic Solution
Ciprofloxacin 400 MG/200 ML Intravenous Solution [CIPRO IV]

Campinas, Brazil

University of Campinas

Dec 6, 2021

Pulmonary Disease, Lung Disease, Moxifloxacin Trial in Bruxelles (PF-00610355, moxifloxacin, )

Completed

Pulmonary Disease
+2 more

PF-00610355
+2 more

Bruxelles, Belgium

Pfizer Investigational Site

Jan 12, 2011